Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-07 5:05 pm Unchanged | 13G | LYRA THERAPEUTICS INC LYRA | Polaris Venture Partners V L.P. | 1,423,772 4.5% | 0 (Unchanged) | View |
| 2022-06-24 4:47 pm Unchanged | 13D | INVIVYD, INC. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.8% | 0 (Unchanged) | View |
| 2022-04-25 9:41 pm Unchanged | 13D | INVIVYD, INC. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.8% | 0 (Unchanged) | View |
| 2022-03-30 07:37 am Unchanged | 13D | INVIVYD, INC. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.7% | 0 (Unchanged) | View |
| 2021-08-20 4:21 pm Purchase | 13D | INVIVYD, INC. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.7% | 8,531,700 (New Position) | View |
| 2021-02-12 5:15 pm Sale | 13G | PHREESIA INC PHR | Polaris Venture Partners V L.P. | 0 0% | -3,214,092 (Position Closed) | View |
| 2021-02-12 5:10 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Polaris Venture Partners V L.P. | 1,423,772 11% | 1,423,772 (New Position) | View |
| 2020-02-12 4:55 pm Sale | 13G | KALA PHARMACEUTICALS INC KALA | Polaris Venture Partners V L.P. | 598,620 1.7% | -1,292,293 (-68.34%) | View |
| 2020-02-12 4:52 pm Purchase | 13G | PHREESIA INC PHR | Polaris Venture Partners V L.P. | 3,214,092 9% | 3,214,092 (New Position) | View |
| 2020-02-12 4:42 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | Polaris Venture Partners V L.P. | 2,789,889 3.2% | 10,000 (+0.36%) | View |
| 2020-02-12 4:34 pm Sale | 13G | CARDLYTICS INC CDLX | Polaris Venture Partners V L.P. | 9,010 0% | -2,543,616 (-99.65%) | View |
| 2019-07-17 4:56 pm Sale | 13D | PULMATRIX INC PULM | Polaris Venture Partners V L.P. | 760,851 3.8% | -6,749,336 (-89.87%) | View |
| 2019-07-17 4:52 pm Purchase | 13D | X4 PHARMACEUTICALS INC XFOR | Polaris Venture Partners V L.P. | 311,492 2.5% | 311,492 (New Position) | View |
| 2019-07-17 4:44 pm Sale | 13D | ATYR PHARMA INC LIFE | Polaris Venture Partners V L.P. | 130,571 3.7% | -21,697,421 (-99.40%) | View |